Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses
Frontiers in Microbiology · 18.04.2023 · 14
DOI: 10.3389/fmicb.2023.1126808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 18.04.2023. Verfasst von Hao Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province), College of Pharmacy, Harbin Medical, Unive…. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Many lines of evidence demonstrate the associations of colorectal cancer (CRC) with intestinal microbial dysbiosis. Recent reports have suggested that maintaining the homeostasis of microbiota and host might be beneficial to CRC patients, but the underlying mechanisms remain unclear. In this study, we established a CRC mouse model of microbial dysbiosis and evaluated the effects of fecal microbiota transplantation (FMT) on CRC progression. Azomethane and dextran sodium sulfate were used to induce CRC and microbial dysbiosis in mice. Intestinal microbes from healthy mice were transferred to CRC mice by enema. The vastly disordered gut microbiota of CRC mice was largely reversed by FMT. Intestinal microbiota from normal mice effectively suppressed cancer progression as assessed by measuring the diameter and number of cancerous foci and significantly prolonged survival of the CRC mice. In the intestine of mice that had received FMT, there were massive infiltration of immune cells, including CD8 + T and CD49b + NK, which is able to directly kill cancer cells. Moreover, the accumulation of immunosuppressive cells, Foxp3 + Treg cells, seen in the CRC mice was much reduced after FMT. Additionally, FMT regulated the expressions of inflammatory cytokines in CRC mice, including down-regulation of IL1a, IL6, IL12a, IL12b, IL17a, and elevation of IL10. These cytokines were positively correlated with Azospirillum_sp._47_25 , Clostridium_sensu_stricto_1 , the E. coli complex, Akkermansia , Turicibacter , and negatively correlated with Muribaculum , Anaeroplasma , Candidatus_Arthromitus , and Candidatus Saccharimonas . Furthermore, the repressed expressions of TGFb, STAT3 and elevated expressions of TNFa, IFNg, CXCR4 together promoted the anti-cancer efficacy. Their expressions were positively correlated with Odoribacter , Lachnospiraceae-UCG-006, Desulfovibrio , and negatively correlated with Alloprevotella , Ruminococcaceae UCG-014, Ruminiclostridium , Prevotellaceae UCG-001 and Oscillibacter . Our studies indicate that FMT inhibits the development of CRC by reversing gut microbial disorder, ameliorating excessive intestinal inflammation and cooperating with anti-cancer immune responses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province), College of Pharmacy, Harbin Medical, University, Harbin, China.
- HMU-UCCSM Centre for Infection and Genomics, Harbin Medical University, Harbin, Heilongjiang, China.
- Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang, China.
- Pathology Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, H., Li, X. X., Han, X., Chen, B. X., Zhang, X. H., Gao, S., Xu, D. Q., Wang, Y., Gao, Z. K., Yu, L., Zhu, S. L., Yao, L. C., Liu, G. R., Liu, S. L., & Mu, X. Q. (2023). Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1126808
Vancouver
Yu H, Li XX, Han X, Chen BX, Zhang XH, Gao S, et al. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1126808
BibTeX
@article{Yu2023,
author = {Yu, Hao and Li, Xing-Xiu and Han, Xing and Chen, Bin-Xin and Zhang, Xing-Hua and Gao, Shan and Xu, Dan-Qi and Wang, Yao and Gao, Zhan-Kui and Yu, Lei and Zhu, Song-Ling and Yao, Li-Chen and Liu, Gui-Rong and Liu, Shu-Lin and Mu, Xiao-Qin},
title = {Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1126808}
}
EUVIMED